tebentafusp,ipilimumab,nivolumab
immunocore,bms,medison
['nivo', 'ipi/', 'melanoma', 'tebentafusp']
very nice discussion by of new studies for difficult to treat #melanoma subtypes at #asco22. nice job of explaining plethora of liver directed therapies available (embolizations, php, etc.) for om. how do we combine these tx best with ipi/nivo and tebentafusp?
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.